Chirawadee Sathitruangsak

Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Miguel Martín, Elgene Lim, Mariana Chávez‐MacGregor et al. · Journal of Clinical Oncology · 2024 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Three-dimensional Nuclear Telomere Organization in Multiple Myeloma

Ludger Klewes, Rhea U. Vallente, Eric Dupas et al. · Translational Oncology · 2013 · 25 citations · Full text

Medicine, Hematology, Oncology +17

Distinct and shared three‐dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma

Chirawadee Sathitruangsak, Christiaan H. Righolt, Ludger Klewes et al. · International Journal of Cancer · 2016 · 21 citations · Full text

Life Sciences, Cell Biology, Genetics +17

Clinical Characteristics and Treatment Outcomes of Patients with Primary Mediastinal Germ Cell Tumors: 10-Years' Experience at a Single Institution with a Bleomycin-Containing Regimen

Arunee Dechaphunkul, Siwat Sakdejayont, Chirawadee Sathitruangsak et al. · Oncology Research and Treatment · 2016 · 20 citations

Medicine, Oncology, Surgery +16

Quantitative Superresolution Microscopy Reveals Differences in Nuclear DNA Organization of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Chirawadee Sathitruangsak, Christiaan H. Righolt, Ludger Klewes et al. · Journal of Cellular Biochemistry · 2014 · 19 citations · Full text

Life Sciences, Cell Biology, Oncology +17